Acts Online
GT Shield

Medicines and Related Substances Control Act, 1965 (Act No. 101 of 1965)

Regulations

General Regulations

Permits, Licensing and Authorisation

26. Permits and authorisation in terms of section 22A

 

(1)

(a) An application for a permit contemplated in section 22A(9)(a)(i) of the Act by a medical practitioner for the use of a Schedule 7 or 8 substance for the treatment or prevention of a medical condition in a particular patient shall contain at least the following information:
(i) Name and address (both physical and postal) of the medical practitioner;
(ii) identification number of the medical practitioner;
(iii) registration number of the medical practitioner with statutory health council;
(iv) qualifications of the medical practitioner;
(v) contact details of the medical practitioner including the—
(aa) telephone number; and
(bb) facsimile number or email address;
(vi) purpose for which the application is made;
(vii) the name and physical address of the patient, diagnosis, dosage and period of treatment; and
(viii) the place where and the manner in which the scheduled substances shall be stored safely.
(b) The Director-General may issue a permit referred to in subregulation (1) only after consultation with the Authority.
(c) A permit referred to in subregulation (1) may not be issued if the Director-General is of the opinion that the applicant is not capable of keeping or storing the substance in a manner so as to prevent the loss or diversion thereof.

 

(2)

(a) An application for a permit contemplated in section 22A(9)(a)(i) of the Act by a veterinarian for the use of a Schedule 7 or Schedule 8 substance for the treatment or prevention of a medical condition in a particular animal shall contain at least the following information:
(i) Name and address (both physical and postal) of the veterinarian;
(ii) identification number of the veterinarian;
(iii) registration number of the veterinarian with the statutory council;
(iv) qualifications of the veterinarian;
(v) contact details of the veterinarian including the—
(aa) telephone number; and
(bb) facsimile number or email address;
(vi) purpose for which the application is made;
(vii) the name and address of the owner of the animal, diagnosis, dosage and period of treatment; and
(viii) the place where and the manner in which the scheduled substances shall be stored safely.
(b) The Director -General may issue a permit referred to in paragraph (a) only after consultation with the Authority.
(c) A permit referred to in paragraph (a) may not be issued if the Director -General is of the opinion that the applicant is not capable of keeping or storing the substance in a manner so as to prevent the loss or diversion thereof.

 

(3)

(a) An application for a permit contemplated in section 22A(9)(a)(i) of the Act by an analyst or researcher desiring to be provided with a Schedule 7 or Schedule 8 substance for the purposes of education, analysis or research, shall contain at least the following information:
(i) Name and address (both physical and postal) of analyst or researcher;
(ii) identification number of analyst or researcher;
(iii) name and address of employer;
(iv) qualifications of the analyst or researcher;
(v) contact details of the analyst of researcher including the:
(aa) telephone number; and
(bb) facsimile number or email address;
(vi) particulars of the intended education, analysis or research project;
(vii) address at which the education, analysis or research will be undertaken;
(viii) estimated duration of project or activity;
(ix) total quantity of scheduled substances to be kept in stock per annum;
(x) source of supply; and
(xi) the place where and the manner in which the scheduled substances shall be stored safely.
(b) The Director-General may issue a permit referred to in paragraph (a) only after consultation with the Authority.
(c) A permit referred to in paragraph (a) may not be issued if the Director-General is of the opinion that the applicant is not capable of keeping or storing the substance in a manner so as to prevent the loss or diversion thereof.

 

(4) An application for a permit contemplated in section 22A(9)(a)(i) of the Act to manufacture any specified Schedule 5 or Schedule 6 substance shall contain at least the following information:
(a) Name and address (both physical and postal) of the applicant;
(b) name and registration number of the responsible pharmacist;
(c) a certified copy of the manufacturing licence issued by the Authority in terms of section 22C(1)(b);
(d) contact details of the applicant including the—
(i) telephone number; and
(ii) facsimile number or email address;
(e) address at which manufacturing is to be undertaken; and
(f) estimated quantity of specified Schedule 5 or Schedule 6 substance that will be manufactured.

 

(5)

(a) An application for a permit contemplated in section 22A(9)(a)(ii) of the Act to manufacture, use or supply a Schedule 5 or Schedule 6 substance for other than medicinal purposes shall contain at least the following information—
(i) name and address (both physical and postal) of applicant;
(ii) contact details of the applicant, including the:
(aa) telephone number; and
(bb) facsimile number or email address;
(iii) name and address of contact person;
(iv) identification number of contact person;
(v) qualifications of the contact person;
(vi) contact details of the contact person, including the—
(aa) telephone number; and
(bb) facsimile number or email address; and
(vii) purpose for which the application is made.
(b) The Director -General may issue a permit referred to in paragraph (a) only after consultation with the Authority.

 

(6)

(a) An application for a permit contemplated in section 22A(7)(a) of the Act shall contain at least the following information:
(i) Name and address (both physical and postal) of applicant;
(ii) contact details of the applicant, including the—
(aa) telephone number; and
(bb) facsimile number or email address;
(iii) name and address of contact person;
(iv) identification number of contact person;
(v) qualifications of the contact person;
(vi) contact details of the contact person, including the—
(aa) telephone number; and
(bb) facsimile number or email address;
(vii) source of supply; and
(viii) the place where and the manner in which the scheduled substances shall be stored safely.
(b) A permit referred to in paragraph (a) may not be issued if the Director-General is of the opinion that the applicant is not capable of keeping or storing the substance in a manner so as to prevent the loss or diversion thereof.

 

(7)

(a) An application for a permit contemplated in section 22A(15) of the Act shall contain at least the following information:
(i) Name and address (both physical and postal) of applicant;
(ii) identification number of applicant;
(iii) name and address of employer;
(iv) qualifications of the applicant;
(v) proof of registration with the relevant statutory health council, if applicable (vi) contact details of the applicant including the—
(aa) telephone number; and
(bb) facsimile number or email address;
(vii) source of supply; and
(viii) the place where and the manner in which the scheduled substances shall be stored safely.
(b) A permit referred to in paragraph (a) may not be issued if the Director-General is of the opinion that the applicant is not capable of keeping or storing the substance in a manner so as to prevent the loss or diversion thereof.
(c) A permit referred to in this subregulation may be withdrawn, revoked or suspended by the Director-General if the person issued with such a permit fails to comply with the conditions or requirements for issuing the permit.

 

(8) A application for an authorisation contemplated in section 22A(10) of the Act shall contain at least the following information:
(a) Name and address (both physical and postal) of medical practitioner;
(b) identification number of the medical practitioner;
(c) registration number of the medical practitioner with statutory health council;
(d) qualifications of the medical practitioner;
(e) contact details of the medical practitioner including the—
(i) telephone number; and
(ii) facsimile number or email address;
(f) purpose for which the application is made; and
(g) the place where and the manner in which the scheduled substances shall be stored safely.

 

(9) Any permit holder or person referred to in this regulation may be subject to regular inspections of the premises or practice in terms of section 28 of the Act.